NewLink Genetics Announces Promising Clinical Data at ECC 2015 By: Benzinga via Benzinga September 27, 2015 at 12:33 PM EDT NewLink Genetics Corporation(NASDAQ: NLNK) announced promising early-stage clinical data from a phase 1a study of GDC-0919, an ... Read More >> Related Stocks: Newlink Genetics Cor Roche Holding AG Basel American Depositary Shares